Biomedical Laboratory Science

ShareThis

Showing posts with label Disease. Show all posts
Showing posts with label Disease. Show all posts

Monday, March 6, 2017

Key Regulator of Intestinal Homeostasis Identified

SP140, an epigenetic reader protein mutated in a number of autoimmune disorders, is essential for macrophage function and preventing intestinal inflammation, scientists show. 


Artist's rendition of a macrophage in the gut and epigenome (green balls are the basic units of chromatin,
with nucleosomes wrapped twice around an octamer of a histone)
Researchers are only beginning to understand the roles of the hundreds of proteins involved in reading, writing, and erasing the epigenome. One of the epigenetic regulators, SP140, which is mutated in a number autoimmune disorders, including Crohn’s disease and multiple sclerosis, is also essential to macrophage function and intestinal homeostasis in both humans and mice, scientists reported today (March 3) in Science Immunology.

“Many immune-mediated disorders are driven by a combination of genetic susceptibility as well as environmental influences [so] epigenetics is a suitable critical juncture between those two aspects of the disease,” said coauthor Kate Jeffrey, a researcher investigating the epigenetic control of innate immunity at Massachusetts General Hospital.

Source: the-scientist

Monday, October 3, 2016

From 230,000 patients to extinct in 15 years: pathology and new drugs key to defeating hepatitis C

An estimated 230,000 Australians have chronic hepatitis C, and a quarter of cases are undiagnosed.

Hepatitis C inflames the liver and unlike the A and B viruses there is no vaccine available. Pathology is important for diagnosing the virus.

Many people with hepatitis C may not experience symptoms, but left untreated the disease can cause cirrhosis (scarring of the liver), which in a small number of cases can lead to liver cancer.


Source: knowpathology

Thursday, September 22, 2016

Cancer: Shutting Down Fat Synthesis In Cancer Cells Stunts Tumor Growth

Tumors have a voracious appetite for fat and rely on hastened fat synthesis in cancer cells to satisfy their need. Now, a new study shows it is possible to use drugs to shut down fat synthesis in cancer cells to stunt tumor growth without harming healthy cells.

A report on the study is published in the journal Nature Medicine.

The discovery - by researchers at the Salk Institute in La Jolla, CA, and collaborators - represents a new frontier in the search for targeted treatments against cancer, a leading cause of disease and premature death worldwide.


The researchers found cells treated with a placebo produced more fat (red, on left) than cells treated
with the enzyme inhibitor (right). Image credit: Salk Institute

This Type Of Vitamin E Could Predict Your Risk For Alzheimer's—And You're Probably Not Getting Enough Of It

Vitamin E is essential for normal neurological function, according to a 2013 Journal of Internal Medicine study, which found that low levels of some types of the vitamin could help predict your risk for Alzheimer's disease. Looking to take back control of your health? 

Some types? That's right: There are different types of vitamin E. In fact, there are 8 varieties or "isoforms" of E, and research suggests your brain needs all of them for optimal health and function.




Wednesday, September 7, 2016

How To Prevent and Treat Fatty Liver

I have a Fatty Liver- Now what?
Many of my clients have digestive issues and think it is to do with a food they are eating. Sometimes they opt for allergy testing, others get blood work or an ultrasound done to see if there are any serious problems.

More and more clients are been diagnosed with a fatty liver and ask me now what do I do?

What is a fatty liver?
A fatty liver is the result of excess fat in the liver. This fat builds up when a person’s diet exceeds the amount of fat their body can handle. Having a fatty liver can lead to fatty liver disease, which then leads to chronic illnesses. Many who are overweight, have belly fat, are insulin resistant, pre- diabetic and who crave sugars and starches are likely have a fatty liver. Yet many who are ultimately healthy and not overweight are finding they to, have a fatty liver.



Monday, September 5, 2016

New Understanding Of Pulmonary Hypertension Leads To Promising Drug Targets

A groundbreaking new study led by researchers from the University of Pittsburgh and UPMC has identified a new group of compounds that could have robust effects in treating pulmonary hypertension (PH), an enigmatic but sometimes fatal disease of the blood vessels of the lungs that currently has no cure. The findings, which were published today in the Journal of Clinical Investigation, highlight the use of these drugs to alter vessel stiffness and its downstream control of metabolism, a link previously unknown for people suffering from the progressive disease.

“If we aim to cure this disease, the next set of medications and treatments should be those that target the origin at the molecular level,” said Stephen Y. Chan, M.D., Ph.D., director of the UPMC Center for Pulmonary Vascular Biology and Medicine at the Vascular Medicine Institute at Pitt, and senior author of the study. “As a community, we are struggling right now to understand those origins of PH, and this study aimed to address that untapped need.”



Source: bioengineer

Crohn's disease: Potential treatment to prevent fibrosis uncovered

Scientists from the University of British Columbia in Canada have found a mutation that switches off a hormone receptor, which prevents mice from developing fibrosis. This discovery could lead to potential treatments to prevent fibrosis in people with Crohn's disease.

Inflammatory bowel disease (IBD) - which includes Crohn's disease and ulcerative colitis - affects around 1.6 million people in the United States. Most people are diagnosed with Crohn's disease before age 35, and while these life-long conditions can be treated, there is currently no cure.

Crohn's disease is a long-term condition that causes inflammation to the lining of the digestive system. While the disease can affect any part of the gastrointestinal tract, the most commonly affected areas are the end of the small intestine (the ileum) or the large intestine (colon).


Scientists can potentially block complications of fibrosis in Crohn's disease by dampening particular
inflammatory cell types.


Friday, September 2, 2016

Antibacterial Soaps Aren't Just Ineffective, They're Potentially Dangerous

With a new ban on antibacterial soap, the US government is finally acknowledging that it’s not just ineffective, it’s also dangerous

Fear is a potent marketing tool. Consider how a Listerine advertising campaign in the 1920s literally turned bad breath into a disease (and sold a ton of mouthwash along the way) or the run on potassium iodide in North America after the Fukushima nuclear power plant disaster in 2011.

Then there are antibacterial soaps and body washes, which have targeted—and arguably created—a widespread fear of disease-causing bacteria lurking on every surface of our homes and bodies. Sales of antibacterial soap skyrocketed during the 2009 H1N1 flu sale and have stayed strong since, as brands marketed their antibacterials as scientifically proven to clean better than the stuff you used to keep by your sink.


Lather up, but just use regular soap. (Mariana Bazo/Reuters)
Source: quartz

What is the Function of the Hypothalamus?

The hypothalamus is a small area in the center of the brain that has many jobs. It plays an important role in hormone production and helps to stimulate many important processes in the body.

When the hypothalamus is not working properly, it can cause problems in the body leading to many disorders. Though diseases of the hypothalamus are uncommon, it is important to keep it healthy to keep the risk low.

Contents of this article:
  1. What is the hypothalamus?
  2. Hypothalamus disorders
  3. Diet tips for hypothalamus health

The hypothalamus plays a huge role in both the endocrine and nervous systems. Head injuries impacting
the hypothalamus are the most common cause of hypothalamic disease. Diets high in saturated fats can
influence and alter the function of the hypothalamus.

Monday, August 29, 2016

How Seizures Affect the Body

Having a seizure can be an alarming experience, and whether yours have been mild or severe, you probably have many questions. Understanding what’s happening to your brain and how it’s affecting your body can be helpful and comforting for you and your loved ones as you learn more about managing your condition.

Epilepsy Symptoms
Epilepsy is a neurological disorder, which affects some or all functions of your brain. It can be caused by mutated genes, brain injury or disease. Since your brain controls everything from movement and balance to memory and emotions, an epileptic episode can disrupt this activity, resulting in a seizure or other unusual behaviors or sensations.



Source: healthguides


Wednesday, July 20, 2016

Amazing Foods That Help Prevent Fatty Liver

Have you been suffering from abdominal pain, nausea, vomiting, fatigue and loss of appetite quite often?

Then, you need to watch out, as these could be the symptoms of a fatty liver disease. In case of fatty liver disease, one tends to develop excess fats within the liver.

Liver is one of the most important vital organs of our body. A certain amount of fat in the liver is normal, but when it increases above the normal (above 5 per cent of the organ's weight), then the person could be at the risk of developing fatty liver disease.




Source: boldsky

Saturday, July 16, 2016

Red Meat Consumption Linked to Kidney Failure

A new study, published in the Journal of the American Society of Nephrology, investigated the long-term impact of red meat consumption on kidney health. Their findings justify the current caution suggested in regard to red meat and organ health.

Red meat, such as beef, lamb, and pork, can be included as part of a healthy diet.

But, as with many dietary components, it is best to limit the amount consumed.

For instance, the American Institute for Cancer Research recommend eating no more than 18 ounces of red meat per month because of its links with certain cancers, including stomach cancer.


Research investigates the effects of red meat on kidney health.

Wednesday, July 6, 2016

Why is My Skin Itchy? Examining the Causes of Itchy Skin

For some people, itchy skin is a constant battle. It can be difficult to understand exactly what is causing the skin to itch.

Itchy skin can be the result of a rash or another skin condition. It can also be a symptom of a more serious condition such as liver disease or kidney failure. To get relief, it is important to identify the problem and treat the underlying cause.

Skin, rashes, and itches
Skin serves a vital purpose as a barrier, protecting the inside of the body.


Itching is one of the most common symptoms of all skin problems.

Saturday, July 2, 2016

Inherited Cholesterol Disorder Significantly Boosts Heart Risks

People who inherit a genetic disorder that causes high levels of "bad" LDL cholesterol have an increased risk for heart disease and hardened arteries, a new study finds.

The condition is called heterozygous familial hypercholesterolemia. It's believed to affect about 1.5 million people in the United States, the researchers said.

The genes linked to this condition prevent the liver from removing LDL (low-density lipoprotein) cholesterol from the blood. This allows the bad cholesterol to build up. Doctors suspect this familial condition when LDL levels are above 190 milligrams per deciliter (mg/dL), the study authors explained.



Sunday, June 26, 2016

New Method Developed for Detecting Mycobacteria in the Lungs

A research team from the Institute of Medical Microbiology at the University of Zurich and the National Center for Mycobacteria has carried out a large-scale study with more than 6800 patient samples to examine molecular-based methods for the detection of mycobacterial pathogens. Because many mycobacteria only grow at a slow pace, routine detection using bacteria cultures in highly specialized and expensive high-safety labs takes several weeks to complete. The subsequent susceptibility test to determine the appropriate medicine also takes 1 to 2 weeks.

"For patients and doctors, this long waiting period is an unnecessary test of their patience", says Peter Keller, M.D., from the Institute of Medical Microbiology at the UZH. "By comparison, with molecular detection methods, most patients know after 1 or 2 days whether they have an infection with tuberculosis pathogens or with nontuberculous mycobacteria."

Mycobacteria cause various illnesses. Mycobacterium tuberculosis, the main representative of this genus, is the causative agent of tuberculosis, which killed around 1.5 million people worldwide in 2014.


Mycobacterium tuberculosis in patient samples.
Source: genengnews

Monday, May 9, 2016

Tools for Lung Cancer Research

Recent advances in lung cancer research suggest a personalized approach to diagnostics and therapeutics to reduce mortality

Due to its high rate of mortality, lung cancer is a prominent area of research for scientists. Lung cancer is a complex disease with many subtypes resulting from factors such as family history, lifestyle and occupation-with each subtype requiring different treatment regimens. Thus, developing therapeutics for this disease requires vast research efforts.

The specific subtypes of the cancer must be paired to successful treatments, which can then be matched to individual patients. The American Type Culture Collection (ATCC) has responded to this initiative for personalized medicine by creating new drug screening and diagnostic test development tools, such as tumor cell panels based on genetic alteration, primary cells, gene-edited isogenic cell lines and cell line derivatives.

"Over the years, we have expanded our portfolio into the most diverse and unique collection of cancer cells to include thousands of human and animal cancer cell lines representing the diversity of the disease," said Fang Tian, PhD, lead scientist at ATCC. "Our growing collection of lung cancer cell lines is now just shy of 100 lines.



Source: laboratory-manager.advanceweb

Friday, May 6, 2016

Gallstones: Epidemiology, Pathophysiology and Management.

Gallstones grow inside the gallbladder or biliary tract. These stones can be asymptomatic or symptomatic; only gallstones with symptoms or complications are defined as gallstone disease. Based on their composition, gallstones are classified into cholesterol gallstones, which represent the predominant entity, and bilirubin (‘pigment’) stones. Black pigment stones can be caused by chronic hemolysis; brown pigment stones typically develop in obstructed and infected bile ducts. For treatment, localization of the gallstones in the biliary tract is more relevant than composition. Overall, up to 20% of adults develop gallstones and >20% of those develop symptoms or complications. Risk factors for gallstones are female sex, age, pregnancy, physical inactivity, obesity and over nutrition. Factors involved in metabolic syndrome increase the risk of developing gallstones and form the basis of primary prevention by lifestyle changes. Common mutations in the hepatic cholesterol transporter ABCG8 confer most of the genetic risk of developing gallstones, which accounts for ∼25% of the total risk. Diagnosis is mainly based on clinical symptoms, abdominal ultrasonography and liver biochemistry tests. Symptoms often precede the onset of the three common and potentially life-threatening complications of gallstones (acute cholecystitis, acute cholangitis and biliary pancreatitis). Although our knowledge on the genetics and pathophysiology of gallstones has expanded recently, current treatment algorithms remain predominantly invasive and are based on surgery. Hence, our future efforts should focus on novel preventive strategies to overcome the onset of gallstones in at-risk patients in particular, but also in the population in general.

Introduction
Gallstones (cholelithiasis) are masses in the gallbladder or biliary tract that are caused by abnormally high levels of either cholesterol or bilirubin (a breakdown product of heme) in bile (Fig. 1). Gallstones are common (∼10–20% of the global adult population), and >20% of people with gallstones will develop symptoms in their lifetime (including biliary colic or infections), usually in adulthood. Gallstone disease is defined by the occurrence of symptoms or complications caused by gallstones in the gallbladder and/or the bile ducts. From a clinical perspective and in treatment algorithms, those with asymptomatic stones are not generally classified as having gallstone disease. Gallstone disease is among the gastrointestinal conditions associated with the highest socioeconomic costs.


Figure 1: Classification of gallstones.
PrimeView Poster:
Gallstones are masses in the gallbladder or biliary tract. 10–20% of adults will develop gallstones in their lifetime, and >20% of those will develop symptoms or complications. This Primer by Lammert et al. focuses on the formation of gallstones, summarizes the current principles of treatment of the stones and their potential complications and envisions future approaches for this widespread disease. And this PrimeView focuses on the most common risk factors, which include genetics, ethnicity, sex, age, drugs, parasites, over nutrition and pregnancy.
Frank Lammert, Kurinchi Gurusamy, Cynthia W. Ko,Juan-Francisco Miquel, Nahum Méndez-Sánchez, Piero Portincasa, Karel J. van Erpecum, Cees J. van Laarhoven& David Q.-H. Wang

View poster: Gallstone Poster (high-resolution PDF (1.30 MB))


Source: NatureReviewsDiseasePrimers
Related Posts Plugin for WordPress, Blogger...

AddToAny